Repatriations, testing and quarantine compliance expenses are a drag on profit in an otherwise robust bulker market, US-listed company’s results show
Author: Capt. John
Repatriations, testing and quarantine compliance expenses are a drag on profit in an otherwise robust bulker market, US-listed company’s results show